Skip to main content
Premium Trial:

Request an Annual Quote

Mayo Clinic Coronavirus Assay Gets Emergency Use Authorization

NEW YORK — The US Food and Drug Administration on Monday granted Emergency Use Authorization for the Mayo Clinic's PCR-based SARS-CoV-2 diagnostic assay.

According to the FDA, the SARS-CoV-2 Molecular Detection Assay is designed to detect RNA from the virus' nucleocapsid and ORF1ab genes in upper and lower respiratory specimens including nasopharyngeal swabs, throat swabs, nasal swabs, sputum, and tracheal secretions.

RNA is isolated using BioMérieux's easyMAG and EMAG extraction instruments, and the test runs on Roche's LightCycler 480 version 1.5.1.62.

Assay testing is limited to the Mayo Clinic's CLIA-certified lab, the FDA said.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.